Respiratory Test Kit BinaxNOW™ Professional Use COVID-19 Ag 40 Tests

Description

  • BinaxNOW COVID-19 Ag Card is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests; this test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
  • Product ships with minimum 60 days dating
  • This test is authorized for use with direct anterior nasal (nares) swab samples from individuals with symptoms of COVID-19 within the first seven days of symptom onset when tested at least twice over three days with at least 48 hours between tests; this test is also authorized for use with direct anterior nasal (nares) swab samples from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested at least three times over five days with at least 48 hours between tests
  • Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities
  • Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status
  • Positive results do not rule out bacterial infection or co-infection with other viruses
  • Negative results should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed
  • Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
  • The BinaxNOW COVID-19 Ag Card is intended for use by medical professionals or trained operators who are proficient in performing rapid lateral flow tests
  • Sensitivity (PPA) 84.6% (entire population)
  • Sensitivity (PPA) 95.6% (those with PCR cycle threshold [Ct] < 33)
  • Specificity (NPA) 98.5%
  • Supplemental data indicates that antigen tests have demonstrated positive percent agreement as high as 100% for symptomatic patients (3 serial tests, 2 days after first PCR positive) and as high as 88.9% for asymptomatic patients (3 serial tests, 6 days after first PCR positive)
  • Onboard extraction allows the swab to be directly inserted into the test card
  • Visually read results in 15 minutes - no instrument required
  • The BinaxNOW COVID-19 Ag Card does not differentiate between SARSCoV and SARS-CoV-2
    NOTE: THIS PRODUCT IS NON-RETURNABLE
Product form

BinaxNOW COVID-19 Ag Card is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations Testing is... Read more

SKU: 1186179

$375.00

    Description

    • BinaxNOW COVID-19 Ag Card is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
    • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests; this test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
    • Product ships with minimum 60 days dating
    • This test is authorized for use with direct anterior nasal (nares) swab samples from individuals with symptoms of COVID-19 within the first seven days of symptom onset when tested at least twice over three days with at least 48 hours between tests; this test is also authorized for use with direct anterior nasal (nares) swab samples from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested at least three times over five days with at least 48 hours between tests
    • Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities
    • Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status
    • Positive results do not rule out bacterial infection or co-infection with other viruses
    • Negative results should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed
    • Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
    • The BinaxNOW COVID-19 Ag Card is intended for use by medical professionals or trained operators who are proficient in performing rapid lateral flow tests
    • Sensitivity (PPA) 84.6% (entire population)
    • Sensitivity (PPA) 95.6% (those with PCR cycle threshold [Ct] < 33)
    • Specificity (NPA) 98.5%
    • Supplemental data indicates that antigen tests have demonstrated positive percent agreement as high as 100% for symptomatic patients (3 serial tests, 2 days after first PCR positive) and as high as 88.9% for asymptomatic patients (3 serial tests, 6 days after first PCR positive)
    • Onboard extraction allows the swab to be directly inserted into the test card
    • Visually read results in 15 minutes - no instrument required
    • The BinaxNOW COVID-19 Ag Card does not differentiate between SARSCoV and SARS-CoV-2
      NOTE: THIS PRODUCT IS NON-RETURNABLE

    Recently viewed products

    Reviews

    Respiratory Test Kit BinaxNOW™ Professional Use COVID-19 Ag 40 Tests

    Respiratory Test Kit BinaxNOW™ Professional Use COVID-19 Ag 40 Tests

    0 out of 5 stars

    This product has no reviews yet

    Write a review

    Footer image

    © 2025 MCI Supplies - Medical Supply Company, Powered by Shopify

      • American Express
      • Apple Pay
      • Diners Club
      • Discover
      • Google Pay
      • Mastercard
      • PayPal
      • Shop Pay
      • Venmo
      • Visa

      Login

      Forgot your password?

      Don't have an account yet?
      Create account